Tag: amyotrophic lateral sclerosis

Clinical Trials, FDA, Regulations, Research and Development

FDA Advisory Panel Narrowly Votes Against New ALS Drug

March 31, 2022


In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS). The panel’s decision had been closely watched, […]

Clinical Trials, Research and Development

Bad news for Biohaven as verdiperstat flunks first phase 3 test

September 28, 2021

Via: Pharmaphorum

Myeloperoxidase (MPO) inhibitor verdiperstat was no better than placebo in the M-STAR trial in patients with MSA, and looks likely to be abandoned for this indication. It’s not the end of the line for the drug, which Biohaven picked up […]